Publication Name	World Journal of Dermatology
Manuscript ID	22381
Country	Netherlands

Received	2015-08-28 10:04
Peer-Review Started	2015-08-31 17:02
To Make the First Decision	2015-09-28 12:09
Return for Revision	2015-10-10 09:39
Revised	2015-10-19 00:24
Second Decision	2015-12-04 17:24
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-12-14 17:43
Articles in Press	2015-12-14 17:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-16 19:37
Publish the Manuscript Online	2016-01-29 17:09

ISSN	2218-6190 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pediatrics
Manuscript Type	Review
Article Title	Propranolol for infantile hemangioma: Current state of affairs
Manuscript Source	Invited Manuscript
All Author List	Andre V Moyakine and Carine JM van der Vleuten
Funding Agency and Grant Number
Corresponding Author	Andre V Moyakine, MD, Department of Dermatology, Hecovan Expertise Centre for Hemangioma and Vascular Malformations, Radboud University Medical Centre, PO box 9101, Nijmegen, 6500 HB Gelderland, The Netherlands. andre.moyakine@radboudumc.nl
Key Words	Infantile hemangioma; Propranolol; Beta-blocker; Adverse effect; Development
Core Tip	The discovery that propranolol is efficacious in the treatment of infantile hemangioma (IH) has led to an upsurge in publications, increasing our knowledge of this subject. In this review, we provide the most up-to-date information on the pathophysiology, variations in clinical presentation, and natural history of IH. We look at possible working mechanisms of several treatments and the current concerns regarding the treatment of first choice, propranolol. Finally, we provide an overview of instruments, measuring IH severity and/or activity and IH-related quality of life.
Publish Date	2016-01-29 17:09
Citation	Moyakine AV, van der Vleuten CJM. Propranolol for infantile hemangioma: Current state of affairs. World J Dermatol 2016; 5(1): 4-16
URL	http://www.wjgnet.com/2218-6190/full/v5/i1/4.htm
DOI	http://dx.doi.org/10.5314/wjd.v5.i1.4

Full Article (PDF)	WJD-5-4.pdf
Full Article (Word)	WJD-5-4.doc
Manuscript File	22381-Review.docx
Answering Reviewers	22381-Answering reviewers.pdf
Audio Core Tip	22381-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22381-Conflict-of-interest statement.pdf
Copyright License Agreement	22381-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	Informed_Consent_Statement_20150827175635.pdf
Non-Native Speakers of English Editing Certificate	22381-Language certificate.pdf
Peer-review Report	22381-Peer-review(s).pdf
Scientific Misconduct Check	22381-Scientific misconduct check.pdf
Scientific Editor Work List	22381-Scientific editor work list.pdf